Muriel Caslake

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bell Samira; Cooney Josephine; Packard Christopher J; Caslake Muriel; Deighan Christopher J
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria.
Caslake Muriel J; Miles Elizabeth A; Kofler Bettina M; Lietz Georg; Curtis Peter; Armah Christopher K; Kimber Alan C; Grew Jilly P; Farrell Lesley; Stannard Julie; Napper Frances L; Sala-Vila Aleix; West Annette L; Mathers John C; Packard Christopher; Williams Christine M; Calder Philip C; Minihane Anne M
Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.
Burton F L; Malkova D; Caslake M J; Gill J M R
Energy replacement attenuates the effects of prior moderate exercise on postprandial metabolism in overweight/obese men.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Muriel Caslake (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bell Samira; Cooney Josephine; Packard Christopher J; Caslake Muriel; Deighan Christopher J
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria.
Atherosclerosis 2009;205(1):296-301.
2008: Caslake Muriel J; Miles Elizabeth A; Kofler Bettina M; Lietz Georg; Curtis Peter; Armah Christopher K; Kimber Alan C; Grew Jilly P; Farrell Lesley; Stannard Julie; Napper Frances L; Sala-Vila Aleix; West Annette L; Mathers John C; Packard Christopher; Williams Christine M; Calder Philip C; Minihane Anne M
Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.
The American journal of clinical nutrition 2008;88(3):618-29.
2008: Burton F L; Malkova D; Caslake M J; Gill J M R
Energy replacement attenuates the effects of prior moderate exercise on postprandial metabolism in overweight/obese men.
International journal of obesity (2005) 2008;32(3):481-9.
2008: Takagi Toshiyuki; Matsuda Morihiro; Abe Manabu; Kobayashi Hironori; Fukuhara Atsunori; Komuro Ryutaro; Kihara Shinji; Caslake Muriel J; McMahon Alex; Shepherd James; Funahashi Tohru; Shimomura Iichiro
Effect of pravastatin on the development of diabetes and adiponectin production.
Atherosclerosis 2008;196(1):114-21.
2007: Meyer Barbara J; Duvillard Laurence; Owen Alice; Packard Christopher J; Caslake Muriel J
Fractionation of cholesteryl ester rich intermediate density lipoprotein subpopulations by chondroitin sulphate.
Atherosclerosis 2007;195(2):e28-34.
2007: Packard Chris J; Westendorp Rudi G J; Stott David J; Caslake Muriel J; Murray Heather M; Shepherd James; Blauw Gerard J; Murphy Michael B; Bollen Edward L E M; Buckley Brendan M; Cobbe Stuart M; Ford Ian; Gaw Allan; Hyland Michael; Jukema J Wouter; Kamper Adriaan M; Macfarlane Peter W; Jolles Jellemer; Perry Ivan J; Sweeney Brian J; Twomey Cillian;
Association between apolipoprotein E4 and cognitive decline in elderly adults.
Journal of the American Geriatrics Society 2007;55(11):1777-85.
2007: Adiels M; Westerbacka J; Soro-Paavonen A; Häkkinen A M; Vehkavaara S; Caslake M J; Packard C; Olofsson S O; Yki-Järvinen H; Taskinen M R; Borén J
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.
Diabetologia 2007;50(11):2356-65.
2007: Al-Shayji Iqbal A R; Gill Jason M R; Cooney Josephine; Siddiqui Samira; Caslake Muriel J
Development of a novel method to determine very low density lipoprotein kinetics.
Journal of lipid research 2007;48(9):2086-95.
2007: Gill Jason M R; Al-Mamari Ali; Ferrell William R; Cleland Stephen J; Perry Colin G; Sattar Naveed; Packard Chris J; Caslake Muriel J; Petrie John R
Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: heterogeneity of responses.
Atherosclerosis 2007;194(1):134-43.
2007: Lara Jose J; Economou Maria; Wallace A Michael; Rumley Anne; Lowe Gordon; Slater Christine; Caslake Muriel; Sattar Naveed; Lean Michael E J
Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects.
Atherosclerosis 2007;193(1):213-21.
2007: Solà Rosa; Godàs Gemma; Ribalta Josep; Vallvé Joan-Carles; Girona Josefa; Anguera Anna; Ostos Maadoracion; Recalde Delia; Salazar Juliana; Caslake Muriel; Martín-Luján Francisco; Salas-Salvadó Jordi; Masana Lluís
Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease.
The American journal of clinical nutrition 2007;85(4):1157-63.
2007: Stewart Frances M; Freeman Dilys J; Ramsay Jane E; Greer Ian A; Caslake Muriel; Ferrell William R
Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers.
The Journal of clinical endocrinology and metabolism 2007;92(3):969-75.
2006: Adiels M; Taskinen M-R; Packard C; Caslake M J; Soro-Paavonen A; Westerbacka J; Vehkavaara S; Häkkinen A; Olofsson S-O; Yki-Järvinen H; Borén J
Overproduction of large VLDL particles is driven by increased liver fat content in man.
Diabetologia 2006;49(4):755-65.
2006: Lundahl Björn; Skoglund-Andersson Camilla; Caslake Muriel; Bedford Dorothy; Stewart Philip; Hamsten Anders; Packard Christopher J; Karpe Fredrik
Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.
American journal of physiology. Endocrinology and metabolism 2006;290(4):E739-45.
2006: Gill Jason M R; Al-Mamari Ali; Ferrell William R; Cleland Stephen J; Sattar Naveed; Packard Chris J; Petrie John R; Caslake Muriel J
Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men.
Atherosclerosis 2006;185(1):87-96.
2006: Hayek Tony; Stephens Jeffrey W; Hubbart Christina S; Acharya Jayshree; Caslake Muriel J; Hawe Emma; Miller George J; Hurel Steven J; Humphries Steve E
A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus.
Atherosclerosis 2006;184(2):404-12.
2005: Belo Luís; Santos-Silva Alice; Rocha Susana; Caslake Muriel; Cooney Josephine; Pereira-Leite Luís; Quintanilha Alexandre; Rebelo Irene
Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy.
European journal of obstetrics, gynecology, and reproductive biology 2005;123(1):46-51.
2005: Belo Luís; Santos-Silva Alice; Caslake Muriel; Pereira-Leite Luís; Quintanilha Alexandre; Rebelo Irene
Oxidized-LDL levels in normal and pre-eclamptic pregnancies: contribution of LDL particle size.
Atherosclerosis 2005;183(1):185-6.
2005: Caslake Muriel J; Packard Chris J
Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.
Nature clinical practice. Cardiovascular medicine 2005;2(10):529-35.
2005: Adiels Martin; Borén Jan; Caslake Muriel J; Stewart Philip; Soro Aino; Westerbacka Jukka; Wennberg Bernt; Olofsson Sven-Olof; Packard Chris; Taskinen Marja-Riitta
Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(8):1697-703.
2005: Charakida Marietta; Donald Ann E; Green Hannah; Storry Clare; Clapson Margaret; Caslake Muriel; Dunn David T; Halcox Julian P; Gibb Diana M; Klein Nigel J; Deanfield John E
Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.
Circulation 2005;112(1):103-9.
2005: de Roos Baukje; Caslake Muriel J; Milliner Kevin; Benson G Martin; Suckling Keith E; Packard Chris J
Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
Atherosclerosis 2005;181(1):63-8.
2005: Higgins Siobhan; Gill Jason M R; Janilionyte Rasa; Caslake Muriel J; Malkova Dalia
Physical activity, dietary intake and metabolic risk factors in non-diabetic daughters of patients with type II diabetes.
Preventive medicine 2005;40(2):145-51.
2005: Stephens Jeffrey W; Sozen M Mert; Whittall Ros A; Caslake Muriel J; Bedford Dorothy; Acharya Jayshree; Hurel Steven J; Humphries Steve E
Three novel mutations in the apolipoprotein E gene in a sample of individuals with type 2 diabetes mellitus.
Clinical chemistry 2005;51(1):119-24.
2005: Adiels Martin; Packard Chris; Caslake Muriel J; Stewart Philip; Soro Aino; Westerbacka Jukka; Wennberg Bernt; Olofsson Sven-Olof; Taskinen Marja-Riitta; Borén Jan
A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions.
Journal of lipid research 2005;46(1):58-67.
2004: Gill Jason M R; Al-Mamari Ali; Ferrell William R; Cleland Stephen J; Packard Chris J; Sattar Naveed; Petrie John R; Caslake Muriel J
Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men.
Journal of the American College of Cardiology 2004;44(12):2375-82.
2004: Belo Luís; Caslake Muriel; Santos-Silva Alice; Castro Elisabeth Molnar Bayer; Pereira-Leite Luís; Quintanilha Alexandre; Rebelo Irene
LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study.
Atherosclerosis 2004;177(2):391-9.
2004: Rodie V A; Caslake M J; Stewart F; Sattar N; Ramsay J E; Greer I A; Freeman D J
Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.
Atherosclerosis 2004;176(1):181-7.
2004: Gill Jason M R; Brown Jacqueline C; Bedford Dorothy; Wright Dawn M; Cooney Josephine; Hughes David A; Packard Chris J; Caslake Muriel J
Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects.
Atherosclerosis 2004;176(1):49-56.
2004: Caslake Muriel J; Packard Chris J
Phenotypes, genotypes and response to statin therapy.
Current opinion in lipidology 2004;15(4):387-92.
2004: Menys Valentine C; Liu Yifen; Mackness Michael I; Kwok See; Caslake Muriel J; Stewart Grace; Durrington Paul N
Isolation of plasma small-dense low-density lipoprotein using a simple air-driven ultracentrifuge and quantification using immunoassay of apolipoprotein B.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(1):30-6.
2004: Belo Luís; Gaffney Dairena; Caslake Muriel; Santos-Silva Alice; Pereira-Leite Luís; Quintanilha Alexandre; Rebelo Irene
Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies.
European journal of obstetrics, gynecology, and reproductive biology 2004;112(1):9-15.
2003: Caslake Muriel J; Stewart Grace; Day Stephen P; Daly Elaine; McTaggart Fergus; Chapman M John; Durrington Paul; Laggner Peter; Mackness Michael; Pears John; Packard Chris J
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.
Atherosclerosis 2003;171(2):245-53.
2003: Freeman Dilys J; Samani Nilesh J; Wilson Valerie; McMahon Alex D; Braund Peter S; Cheng Suzanne; Caslake Muriel J; Packard Chris J; Gaffney Dairena
A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
European heart journal 2003;24(20):1833-42.
2003: Gill Jason M R; Caslake Muriel J; McAllister Craig; Tsofliou Fotini; Ferrell William R; Packard Chris J; Malkova Dalia
Effects of short-term detraining on postprandial metabolism, endothelial function, and inflammation in endurance-trained men: dissociation between changes in triglyceride metabolism and endothelial function. j.gill@bio.gla.ac.uk.
The Journal of clinical endocrinology and metabolism 2003;88(9):4328-35.
2003: Kay A D; Day S P; Nicoll J A R; Packard C J; Caslake M J
Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage.
Atherosclerosis 2003;170(1):141-6.
2003: Kay Andrew D; Day Stephen P; Kerr Mary; Nicoll James A R; Packard Chris J; Caslake Muriel J
Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury.
Journal of neurotrauma 2003;20(8):717-23.
2003: Menys Valentine C; Liu Yifen; Mackness Michael I; Caslake Muriel J; Kwok See; Durrington Paul N
Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.
Clinica chimica acta; international journal of clinical chemistry 2003;334(1-2):95-106.
2003: Caslake Muriel J; Packard Chris J
Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease.
Current opinion in lipidology 2003;14(4):347-52.
2003: Gill Jason M R; Brown Jacqueline C; Caslake Muriel J; Wright Dawn M; Cooney Josephine; Bedford Dorothy; Hughes David A; Stanley John C; Packard Chris J
Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL.
The American journal of clinical nutrition 2003;78(1):47-56.
2003: Chapman M John; Caslake Muriel; Packard Chris; McTaggart Fergus
New dimension of statin action on ApoB atherogenicity.
Clinical cardiology 2003;26(1 Suppl 1):I7-10.
2003: Belo Luís; Santos-Silva Alice; Caslake Muriel; Cooney Josephine; Pereira-Leite Luís; Quintanilha Alexandre; Rebelo Irene
Neutrophil activation and C-reactive protein concentration in preeclampsia.
Hypertension in pregnancy : official journal of the International Society for the Study of Hypertension in Pregnancy 2003;22(2):129-41.
2002: Belo Luís; Caslake Muriel; Santos-Silva Alice; Pereira-Leite Luís; Quintanilha Alexandre; Rebelo Irene
Lipoprotein(a): a longitudinal versus a cross-sectional study in normal pregnancy and its levels in preeclampsia.
Atherosclerosis 2002;165(2):393-5.
2002: Muriithi Elijah W; Belcher Philip R; Day Stephen P; Chaudhry Mubarak A; Caslake Muriel J; Wheatley David J
Lipolysis generates platelet dysfunction after in vivo heparin administration.
Clinical science (London, England : 1979) 2002;103(4):433-40.
2002: Cho Hong Keun; Shin Gilja; Ryu Sung Kee; Jang Yangsoo; Day Stephen P; Stewart Grace; Packard Chris J; Shepherd James; Caslake Muriel J
Regulation of small dense LDL concentration in Korean and Scottish men and women.
Atherosclerosis 2002;164(1):187-93.
2002: Forster Lorne F; Stewart Grace; Bedford Dorothy; Stewart James P; Rogers Elizabeth; Shepherd James; Packard Chris J; Caslake Muriel J
Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
Atherosclerosis 2002;164(1):129-45.
2002: Belo Luís; Caslake Muriel; Gaffney Dairena; Santos-Silva Alice; Pereira-Leite Luís; Quintanilha Alexandre; Rebelo Irene
Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies.
Atherosclerosis 2002;162(2):425-32.
2002: Freeman Dilys J; Norrie John; Caslake Muriel J; Gaw Allan; Ford Ian; Lowe Gordon D O; O'Reilly Denis St J; Packard Chris J; Sattar Naveed;
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.
Diabetes 2002;51(5):1596-600.
2002: Gaffney Dairena; Forster Lorne; Caslake Muriel J; Bedford Dorothy; Stewart J Philip; Stewart Grace; Wieringa Gilbert; Dominiczak Marek; Miller J Paul; Packard Chris J
Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
Atherosclerosis 2002;162(1):33-43.
2001: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria.
Atherosclerosis 2001;157(1):211-20.
2001: de Roos B; Caslake M J; Ardern H A; Martin Benson G; Suckling K E; Packard C J
Insulin resistance in the St. Thomas' mixed hyperlipidaemic (SMHL) rabbit, a model for familial combined hyperlipidaemia.
Atherosclerosis 2001;156(2):249-54.
2001: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease.
Journal of the American Society of Nephrology : JASN 2001;12(2):341-8.
2001: de Roos B; Caslake M J; Stalenhoef A F; Bedford D; Demacker P N; Katan M B; Packard C J
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects.
The American journal of clinical nutrition 2001;73(1):45-52.
2000: Meyer B J; Caslake M J; McConnell M M; Packard C J
Two subpopulations of intermediate density lipoprotein and their relationship to plasma triglyceride and cholesterol levels.
Atherosclerosis 2000;153(2):355-62.
2000: Packard C J; O'Reilly D S; Caslake M J; McMahon A D; Ford I; Cooney J; Macphee C H; Suckling K E; Krishna M; Wilkinson F E; Rumley A; Lowe G D
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
The New England journal of medicine 2000;343(16):1148-55.
2000: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
Kidney international 2000;58(3):1238-46.
2000: Packard C; Caslake M; Shepherd J
The role of small, dense low density lipoprotein (LDL): a new look.
International journal of cardiology 2000;74 Suppl 1():S17-22.
2000: Caslake M J; Packard C J; Suckling K E; Holmes S D; Chamberlain P; Macphee C H
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease.
Atherosclerosis 2000;150(2):413-9.
2000: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;35(5):852-62.
2000: Packard C J; Demant T; Stewart J P; Bedford D; Caslake M J; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
Journal of lipid research 2000;41(2):305-18.
2000: Friedlander Y; Kidron M; Caslake M; Lamb T; McConnell M; Bar-On H
Low density lipoprotein particle size and risk factors of insulin resistance syndrome.
Atherosclerosis 2000;148(1):141-9.
1999: Ardern H A; Benson G M; Suckling K E; Caslake M J; Shepherd J; Packard C J
Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit.
Journal of lipid research 1999;40(12):2234-43.
1999: Malmström R; Packard C J; Caslake M; Bedford D; Stewart P; Shepherd J; Taskinen M R
Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.
Atherosclerosis 1999;146(2):381-90.
1998: Freeman D J; Caslake M J; Griffin B A; Hinnie J; Tan C E; Watson T D; Packard C J; Shepherd J
The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma.
European journal of clinical investigation 1998;28(7):584-91.
1998: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Increased atherogenicity of low-density lipoprotein in heavy proteinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(5):1183-8.
1998: Malmström R; Packard C J; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen M R
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Diabetes 1998;47(5):779-87.
1997: Malmström R; Packard C J; Watson T D; Rannikko S; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen M R
Metabolic basis of hypotriglyceridemic effects of insulin in normal men.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(7):1454-64.
1997: Malmström R; Packard C J; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen M R
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Diabetologia 1997;40(4):454-62.
1996: Gaw A; Packard C J; Lindsay G M; Murray E F; Griffin B A; Caslake M J; Colquhoun I; Wheatley D J; Lorimer A R; Shepherd J
Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolism.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):236-49.
1996: Bjorkegren J; Packard C J; Hamsten A; Bedford D; Caslake M; Foster L; Shepherd J; Stewart P; Karpe F
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
Journal of lipid research 1996;37(1):76-86.
1995: Tan C E; Foster L; Caslake M J; Bedford D; Watson T D; McConnell M; Packard C J; Shepherd J
Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(11):1839-48.
1995: Gaffney D; Reid J M; Cameron I M; Vass K; Caslake M J; Shepherd J; Packard C J
Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(8):1025-9.
1995: Gaw A; Packard C J; Lindsay G M; Griffin B A; Caslake M J; Lorimer A R; Shepherd J
Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
Journal of lipid research 1995;36(1):158-71.
1994: Gaw A; Packard C J; Caslake M J; Griffin B A; Lindsay G M; Thomson J; Vallance B D; Wosornu D; Shepherd J
Effects of ciprofibrate on LDL metabolism in man.
Atherosclerosis 1994;108(2):137-48.
1994: Watson T D; Caslake M J; Freeman D J; Griffin B A; Hinnie J; Packard C J; Shepherd J
Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(6):902-10.
1994: Griffin B A; Freeman D J; Tait G W; Thomson J; Caslake M J; Packard C J; Shepherd J
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.
Atherosclerosis 1994;106(2):241-53.
1993: Griffin B; Farish E; Walsh D; Barnes J; Caslake M; Shepherd J; Hart D
Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause.
Clinical endocrinology 1993;39(4):463-8.
1993: Caslake M J; Packard C J; Gaw A; Murray E; Griffin B A; Vallance B D; Shepherd J
Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(5):702-11.
1993: Gaw A; Packard C J; Murray E F; Lindsay G M; Griffin B A; Caslake M J; Vallance B D; Lorimer A R; Shepherd J
Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(2):170-89.
1992: Griffin B A; Caslake M J; Gaw A; Yip B; Packard C J; Shepherd J
Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects.
European journal of clinical investigation 1992;22(6):383-90.
1992: Caslake M J; Packard C J; Series J J; Yip B; Dagen M M; Shepherd J
Plasma triglyceride and low density lipoprotein metabolism.
European journal of clinical investigation 1992;22(2):96-104.
1991: Wojciechowski A P; Farrall M; Cullen P; Wilson T M; Bayliss J D; Farren B; Griffin B A; Caslake M J; Packard C J; Shepherd J
Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.
Nature 1991;349(6305):161-4.
1990: Gaw A; Griffin B A; Gaffney D; Caslake M J; Packard C J; Shepherd J
Genetic and environmental modulation of low-density lipoprotein catabolism.
Biochemical Society transactions 1990;18(6):1072-4.
1990: Griffin B A; Caslake M J; Yip B; Tait G W; Packard C J; Shepherd J
Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation.
Atherosclerosis 1990;83(1):59-67.
1990: Warwick G L; Caslake M J; Boulton-Jones J M; Dagen M; Packard C J; Shepherd J
Low-density lipoprotein metabolism in the nephrotic syndrome.
Metabolism: clinical and experimental 1990;39(2):187-92.
1989: Series J; Cameron I; Caslake M; Gaffney D; Packard C J; Shepherd J
The Xba1 polymorphism of the apolipoprotein B gene influences the degradation of low density lipoprotein in vitro.
Biochimica et biophysica acta 1989;1003(2):183-8.
1989: Series J J; Caslake M J; Kilday C; Cruickshank A; Demant T; Lorimer A R; Packard C J; Shepherd J
Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
Metabolism: clinical and experimental 1989;38(2):153-8.
1989: Converse C A; Keegan W A; Huq L; Series J; Caslake M; McLachlan T; Packard C J; Shepherd J
Further epidemiological studies on lipid metabolism in retinitis pigmentosa.
Progress in clinical and biological research 1989;314():39-47.
1988: Demant T; Houlston R S; Caslake M J; Series J J; Shepherd J; Packard C J; Humphries S E
Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene.
The Journal of clinical investigation 1988;82(3):797-802.
1988: Series J J; Caslake M J; Kilday C; Cruickshank A; Demant T; Packard C J; Shepherd J
Influence of etofibrate on low density lipoprotein metabolism.
Atherosclerosis 1988;69(2-3):233-9.
1985: Shepherd J; Caslake M J; Lorimer A R; Vallance B D; Packard C J
Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects.
Arteriosclerosis (Dallas, Tex.) 1985;5(2):162-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Muriel Caslake

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Muriel Caslake (preview)

All Publications